Zinc Therapy in Critical Illness

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

September 30, 2017

Study Completion Date

December 31, 2025

Conditions
Severe Sepsis
Interventions
DIETARY_SUPPLEMENT

Zinc sulfate

"A group of 10 mechanically ventilated patients with severe sepsis will be randomized to receive 500mcg/kg IBW elemental zinc (IV) or placebo. The dose will be escalated by 250mcg/kg IBW every 10 subjects to ceiling dose of 1250 mcg/kg IBW or until toxicity develops.~A group of healthy volunteers will also receive IV zinc (as a single dose) and the PK will be compared to that in patients with sepsis."

Trial Locations (1)

05405

University of Vermont College of Medicine, Burlington

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Vermont

OTHER